Review



customised 11 kb oligonucleotide-microarray  (Agilent technologies)


Bioz Verified Symbol Agilent technologies is a verified supplier
Bioz Manufacturer Symbol Agilent technologies manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Agilent technologies customised 11 kb oligonucleotide-microarray
    Relative expression levels of GATA-4 and friend-of-GATA ( FOG )-2 according to <t>microarray</t> analyses. ( A – D ) GATA-4 and ( E – H ) FOG-2 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =32 for GATA-4 ; n =33 for FOG-2 ). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Boxes: median expression values (horizontal line) and twenty-fifth and seventy-fifth percentiles; whiskers: distances from the end of the box to the largest and smallest observed values that are <1.5 box lengths from either end of the box; open circles: outlying values; asterisks: extreme values. ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.
    Customised 11 Kb Oligonucleotide Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/customised+oligonucleotide+microarray/pmc02768442-36-29-31
    Average 90 stars, based on 1 article reviews
    customised 11 kb oligonucleotide-microarray - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes"

    Article Title: GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes

    Journal: British Journal of Cancer

    doi: 10.1038/sj.bjc.6605276

    Relative expression levels of GATA-4 and friend-of-GATA ( FOG )-2 according to microarray analyses. ( A – D ) GATA-4 and ( E – H ) FOG-2 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =32 for GATA-4 ; n =33 for FOG-2 ). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Boxes: median expression values (horizontal line) and twenty-fifth and seventy-fifth percentiles; whiskers: distances from the end of the box to the largest and smallest observed values that are <1.5 box lengths from either end of the box; open circles: outlying values; asterisks: extreme values. ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.
    Figure Legend Snippet: Relative expression levels of GATA-4 and friend-of-GATA ( FOG )-2 according to microarray analyses. ( A – D ) GATA-4 and ( E – H ) FOG-2 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =32 for GATA-4 ; n =33 for FOG-2 ). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Boxes: median expression values (horizontal line) and twenty-fifth and seventy-fifth percentiles; whiskers: distances from the end of the box to the largest and smallest observed values that are <1.5 box lengths from either end of the box; open circles: outlying values; asterisks: extreme values. ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.

    Techniques Used: Expressing, Microarray, Amplification, MANN-WHITNEY

    Relative expression levels of GATA-2 and -3 according to microarray analyses. ( A – D ) GATA-2 and ( E – H ) GATA-3 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =33). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Box plots represent data as in . * P <0.05; ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.
    Figure Legend Snippet: Relative expression levels of GATA-2 and -3 according to microarray analyses. ( A – D ) GATA-2 and ( E – H ) GATA-3 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =33). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Box plots represent data as in . * P <0.05; ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.

    Techniques Used: Expressing, Microarray, Amplification, MANN-WHITNEY

    Related Articles

    Microarray:

    Article Title: Characterization of a newly developed chicken 44K Agilent microarray
    Article Snippet: .. A long oligonucleotide microarray has been manually curated and designed by our group and manufactured using Agilent inkjet technology. ..

    Article Title: Defining E3 ligase-substrate relationships through multiplex CRISPR screening.
    Article Snippet: .. A pool of sgRNAs targeting 187 BTB adaptors at a depth of 6 sgRNAs/gene were synthesized on an oligonucleotide microarray (Agilent) and cloned into the lentiCRISPR v2 vector as described above. ..

    Article Title: Reliable Single Cell Array CGH for Clinical Samples
    Article Snippet: .. This could be achieved by combined use of Ampli1TM WGA technology together with customized DNA labeling technique and high-resolution Agilent SurePrint G3 Human 4×180 k oligonucleotide microarray platform. ..

    Article Title: Treatment of Glucocorticoids Inhibited Early Immune Responses and Impaired Cardiac Repair in Adult Zebrafish
    Article Snippet: .. To assess the overall differential transcript expression in the initial phase of cardiac repair, we compared the overall gene expression profiles of hearts sampled under three conditions: no-injury, 1dpa-vehicle (i.e., normal healing), and 1dpa-beclomethasone (i.e., impaired healing), using the Agilent zebrafish specific 60-mer oligonucleotide microarray. ..

    Article Title: The Odilorhabdin Antibiotic Biosynthetic Cluster and Acetyltransferase Self-Resistance Locus Are Niche and Species Specific.
    Article Snippet: .. The Agilent oligonucleotide microarray used in this study carries two or three 60-mer probes per sequence of interest. .. The 40 sequences of interest were either NRPS-PKS modules or nonmodular genes associated with NRPS-PKS loci identified in the genomic sequences of X. nematophila ATCC 19061T and P. laumondii TT01T (Fig. S7).

    Article Title: Mitochondrial MICOS complex genes, implicated in hypoplastic left heart syndrome, maintain cardiac contractility and actomyosin integrity
    Article Snippet: .. To detect aneuploidy, array comparative genomic hybridization was performed using a custom 180 K oligonucleotide microarray (Agilent, Santa Clara, CA), with a genome- wide functional resolution of approximately 100 kilobases. ..

    Article Title: Defining E3 ligase–substrate relationships through multiplex CRISPR screening
    Article Snippet: .. Nucleotide sequences encoding a series of 24-mer peptide tiles starting at 6-mer intervals across the 540 ORFs (a total of 33,566 sequences) were synthesized on an oligonucleotide microarray (Agilent), amplified by PCR, and cloned into a lentiviral GPS vector downstream of GFP by Gibson assembly. ..

    Synthesized:

    Article Title: Defining E3 ligase-substrate relationships through multiplex CRISPR screening.
    Article Snippet: .. A pool of sgRNAs targeting 187 BTB adaptors at a depth of 6 sgRNAs/gene were synthesized on an oligonucleotide microarray (Agilent) and cloned into the lentiCRISPR v2 vector as described above. ..

    Article Title: Defining E3 ligase–substrate relationships through multiplex CRISPR screening
    Article Snippet: .. Nucleotide sequences encoding a series of 24-mer peptide tiles starting at 6-mer intervals across the 540 ORFs (a total of 33,566 sequences) were synthesized on an oligonucleotide microarray (Agilent), amplified by PCR, and cloned into a lentiviral GPS vector downstream of GFP by Gibson assembly. ..

    Clone Assay:

    Article Title: Defining E3 ligase-substrate relationships through multiplex CRISPR screening.
    Article Snippet: .. A pool of sgRNAs targeting 187 BTB adaptors at a depth of 6 sgRNAs/gene were synthesized on an oligonucleotide microarray (Agilent) and cloned into the lentiCRISPR v2 vector as described above. ..

    Article Title: Defining E3 ligase–substrate relationships through multiplex CRISPR screening
    Article Snippet: .. Nucleotide sequences encoding a series of 24-mer peptide tiles starting at 6-mer intervals across the 540 ORFs (a total of 33,566 sequences) were synthesized on an oligonucleotide microarray (Agilent), amplified by PCR, and cloned into a lentiviral GPS vector downstream of GFP by Gibson assembly. ..

    Plasmid Preparation:

    Article Title: Defining E3 ligase-substrate relationships through multiplex CRISPR screening.
    Article Snippet: .. A pool of sgRNAs targeting 187 BTB adaptors at a depth of 6 sgRNAs/gene were synthesized on an oligonucleotide microarray (Agilent) and cloned into the lentiCRISPR v2 vector as described above. ..

    Article Title: Defining E3 ligase–substrate relationships through multiplex CRISPR screening
    Article Snippet: .. Nucleotide sequences encoding a series of 24-mer peptide tiles starting at 6-mer intervals across the 540 ORFs (a total of 33,566 sequences) were synthesized on an oligonucleotide microarray (Agilent), amplified by PCR, and cloned into a lentiviral GPS vector downstream of GFP by Gibson assembly. ..

    Whole Genome Amplification:

    Article Title: Reliable Single Cell Array CGH for Clinical Samples
    Article Snippet: .. This could be achieved by combined use of Ampli1TM WGA technology together with customized DNA labeling technique and high-resolution Agilent SurePrint G3 Human 4×180 k oligonucleotide microarray platform. ..

    DNA Labeling:

    Article Title: Reliable Single Cell Array CGH for Clinical Samples
    Article Snippet: .. This could be achieved by combined use of Ampli1TM WGA technology together with customized DNA labeling technique and high-resolution Agilent SurePrint G3 Human 4×180 k oligonucleotide microarray platform. ..

    Expressing:

    Article Title: Treatment of Glucocorticoids Inhibited Early Immune Responses and Impaired Cardiac Repair in Adult Zebrafish
    Article Snippet: .. To assess the overall differential transcript expression in the initial phase of cardiac repair, we compared the overall gene expression profiles of hearts sampled under three conditions: no-injury, 1dpa-vehicle (i.e., normal healing), and 1dpa-beclomethasone (i.e., impaired healing), using the Agilent zebrafish specific 60-mer oligonucleotide microarray. ..

    Gene Expression:

    Article Title: Treatment of Glucocorticoids Inhibited Early Immune Responses and Impaired Cardiac Repair in Adult Zebrafish
    Article Snippet: .. To assess the overall differential transcript expression in the initial phase of cardiac repair, we compared the overall gene expression profiles of hearts sampled under three conditions: no-injury, 1dpa-vehicle (i.e., normal healing), and 1dpa-beclomethasone (i.e., impaired healing), using the Agilent zebrafish specific 60-mer oligonucleotide microarray. ..

    Sequencing:

    Article Title: The Odilorhabdin Antibiotic Biosynthetic Cluster and Acetyltransferase Self-Resistance Locus Are Niche and Species Specific.
    Article Snippet: .. The Agilent oligonucleotide microarray used in this study carries two or three 60-mer probes per sequence of interest. .. The 40 sequences of interest were either NRPS-PKS modules or nonmodular genes associated with NRPS-PKS loci identified in the genomic sequences of X. nematophila ATCC 19061T and P. laumondii TT01T (Fig. S7).

    Hybridization:

    Article Title: Mitochondrial MICOS complex genes, implicated in hypoplastic left heart syndrome, maintain cardiac contractility and actomyosin integrity
    Article Snippet: .. To detect aneuploidy, array comparative genomic hybridization was performed using a custom 180 K oligonucleotide microarray (Agilent, Santa Clara, CA), with a genome- wide functional resolution of approximately 100 kilobases. ..

    Genome Wide:

    Article Title: Mitochondrial MICOS complex genes, implicated in hypoplastic left heart syndrome, maintain cardiac contractility and actomyosin integrity
    Article Snippet: .. To detect aneuploidy, array comparative genomic hybridization was performed using a custom 180 K oligonucleotide microarray (Agilent, Santa Clara, CA), with a genome- wide functional resolution of approximately 100 kilobases. ..

    Functional Assay:

    Article Title: Mitochondrial MICOS complex genes, implicated in hypoplastic left heart syndrome, maintain cardiac contractility and actomyosin integrity
    Article Snippet: .. To detect aneuploidy, array comparative genomic hybridization was performed using a custom 180 K oligonucleotide microarray (Agilent, Santa Clara, CA), with a genome- wide functional resolution of approximately 100 kilobases. ..

    Amplification:

    Article Title: Defining E3 ligase–substrate relationships through multiplex CRISPR screening
    Article Snippet: .. Nucleotide sequences encoding a series of 24-mer peptide tiles starting at 6-mer intervals across the 540 ORFs (a total of 33,566 sequences) were synthesized on an oligonucleotide microarray (Agilent), amplified by PCR, and cloned into a lentiviral GPS vector downstream of GFP by Gibson assembly. ..

    Polymerase Chain Reaction:

    Article Title: Defining E3 ligase–substrate relationships through multiplex CRISPR screening
    Article Snippet: .. Nucleotide sequences encoding a series of 24-mer peptide tiles starting at 6-mer intervals across the 540 ORFs (a total of 33,566 sequences) were synthesized on an oligonucleotide microarray (Agilent), amplified by PCR, and cloned into a lentiviral GPS vector downstream of GFP by Gibson assembly. ..



    Similar Products

    90
    Agilent technologies customised oligonucleotide microarray
    Customised Oligonucleotide Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/customised+oligonucleotide+microarray/pm25195018-60-10-12
    Average 90 stars, based on 1 article reviews
    customised oligonucleotide microarray - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Agilent technologies customised 11 kb oligonucleotide-microarray
    Relative expression levels of GATA-4 and friend-of-GATA ( FOG )-2 according to <t>microarray</t> analyses. ( A – D ) GATA-4 and ( E – H ) FOG-2 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =32 for GATA-4 ; n =33 for FOG-2 ). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Boxes: median expression values (horizontal line) and twenty-fifth and seventy-fifth percentiles; whiskers: distances from the end of the box to the largest and smallest observed values that are <1.5 box lengths from either end of the box; open circles: outlying values; asterisks: extreme values. ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.
    Customised 11 Kb Oligonucleotide Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/customised+oligonucleotide+microarray/pmc02768442-36-29-31
    Average 90 stars, based on 1 article reviews
    customised 11 kb oligonucleotide-microarray - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Relative expression levels of GATA-4 and friend-of-GATA ( FOG )-2 according to microarray analyses. ( A – D ) GATA-4 and ( E – H ) FOG-2 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =32 for GATA-4 ; n =33 for FOG-2 ). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Boxes: median expression values (horizontal line) and twenty-fifth and seventy-fifth percentiles; whiskers: distances from the end of the box to the largest and smallest observed values that are <1.5 box lengths from either end of the box; open circles: outlying values; asterisks: extreme values. ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.

    Journal: British Journal of Cancer

    Article Title: GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes

    doi: 10.1038/sj.bjc.6605276

    Figure Lengend Snippet: Relative expression levels of GATA-4 and friend-of-GATA ( FOG )-2 according to microarray analyses. ( A – D ) GATA-4 and ( E – H ) FOG-2 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =32 for GATA-4 ; n =33 for FOG-2 ). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Boxes: median expression values (horizontal line) and twenty-fifth and seventy-fifth percentiles; whiskers: distances from the end of the box to the largest and smallest observed values that are <1.5 box lengths from either end of the box; open circles: outlying values; asterisks: extreme values. ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.

    Article Snippet: In brief, 1 μ g of linearly amplified Cy3- and Cy5-labelled cRNA was hybridised together with 1 μ g of reverse colour Cy-labelled reference cRNA to a customised 11 kb oligonucleotide-microarray (Agilent Technologies, Waldbronn, Germany).

    Techniques: Expressing, Microarray, Amplification, MANN-WHITNEY

    Relative expression levels of GATA-2 and -3 according to microarray analyses. ( A – D ) GATA-2 and ( E – H ) GATA-3 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =33). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Box plots represent data as in . * P <0.05; ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.

    Journal: British Journal of Cancer

    Article Title: GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes

    doi: 10.1038/sj.bjc.6605276

    Figure Lengend Snippet: Relative expression levels of GATA-2 and -3 according to microarray analyses. ( A – D ) GATA-2 and ( E – H ) GATA-3 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =33). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Box plots represent data as in . * P <0.05; ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.

    Article Snippet: In brief, 1 μ g of linearly amplified Cy3- and Cy5-labelled cRNA was hybridised together with 1 μ g of reverse colour Cy-labelled reference cRNA to a customised 11 kb oligonucleotide-microarray (Agilent Technologies, Waldbronn, Germany).

    Techniques: Expressing, Microarray, Amplification, MANN-WHITNEY